EdgeMarket › Instruments › CERO
CERO — CERO THERAPEUTICS HOLDINGS, INC.
US
Healthcare
Pharma & biotech
equity
mkt cap 6.8M
0.10
+0.00% today
USD · as of 2026-08-21
Price · 2024-08-26 → 2026-08-21
499 daily closes shown52w low 0.10 · high 8.30
Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-11-30.
Performance
1 day+0.00%
1 week+0.00%
1 month+0.00%
3 months+0.00%
6 months+0.00%
Year to date+0.00%
1 year-98.87%
3 years-100.00%
Technicals
RSI 14100.0
vs 50-day avg+0.00%
vs 200-day avg+0.00%
Volatility 1y110.0%
Max drawdown 1y-98.85%
Daily bars held1,186
History from2021-11-30
Others in Healthcare
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2025-03-31 | ATWOOD BRIAN G Director | Option exercise | 294.5K | 0.00 | 0 |
| 2024-12-13 | YK Bioventures Opportunities Fund I, L.P. | Open-market sale | 3.0M | 0.06 | 179.9K |
| 2024-12-13 | Kossar Mitchell William | Open-market sale | 3.0M | 0.06 | 179.9K |
| 2024-12-13 | YK Bioventures Opportunities GP I, LLC | Open-market sale | 3.0M | 0.06 | 179.9K |
| 2024-12-13 | Yeung Gary Kahing | Open-market sale | 3.0M | 0.06 | 179.9K |
| 2024-12-12 | YK Bioventures Opportunities Fund I, L.P. | Open-market sale | 1.6M | 0.07 | 113.0K |
| 2024-12-12 | YK Bioventures Opportunities GP I, LLC | Open-market sale | 1.6M | 0.07 | 113.0K |
| 2024-12-12 | Kossar Mitchell William | Open-market sale | 1.6M | 0.07 | 113.0K |
| 2024-12-12 | Yeung Gary Kahing | Open-market sale | 1.6M | 0.07 | 113.0K |
| 2024-12-11 | Kossar Mitchell William | Open-market sale | 1.3M | 0.08 | 107.5K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 424B3 | 2026-08-14 | — | on EDGAR ↗ |
| 10-Q | 2026-08-14 | 2026-06-30 | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-08-14 | — | on EDGAR ↗ |
| 424B3 | 2026-07-17 | — | on EDGAR ↗ |
| 8-K | 2026-07-17 | 2026-07-14 | on EDGAR ↗ |
| 25-NSE | 2026-07-13 | — | on EDGAR ↗ |
| 424B3 | 2026-06-26 | — | on EDGAR ↗ |
| 8-K | 2026-06-26 | 2026-06-23 | on EDGAR ↗ |
Recent headlines
- CERO THERAPEUTICS HOLDINGS, INC. (CERO) filed form 424B3 · 2026-08-14 · SEC EDGAR
- CERO THERAPEUTICS HOLDINGS, INC. (CERO) filed form 10-Q · 2026-08-14 · SEC EDGAR
- CERO THERAPEUTICS HOLDINGS, INC. (CERO) filed form SCHEDULE 13G/A · 2026-08-14 · SEC EDGAR
Ask the AI about CERO
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →